🔥🐔 BizChicken 🐔🔥
Companies Similar to Karyopharm Therapeutics Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Allarity Therapeutics, Inc.
Stenoparib, Dovitinib, IXEMPRA, Li Pla Cis, 2X-111
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing oncology therapeutics using companion diagnostics and drug response predictor technology.
Careers | Careers | Careers | About | About | About | About | About | About | About | About | Contact | Contact | Contact | Careers | About | About | About | About | About | About | About | About
Symbol: ALLR
Recent Price: $1.12
Industry: Biotechnology
CEO: Mr. Thomas H. Jensen
Sector: Healthcare
Employees: 5
Address: 210 Broadway, Cambridge, MA 02139
Phone: 401 426 4664
Last updated: 2024-12-31
Kiromic BioPharma, Inc.
ALEXIS-ISO-1, ALEXIS-PRO-1
Kiromic Bio Pharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company that develops multi-indication T cell therapies, leveraging the Gamma Delta T cell to target solid tumors. Key products include ALEXIS-ISO-1 and ALEXIS-PRO-1.
Symbol: KRBP
Recent Price: $0.93
Industry: Biotechnology
CEO: Mr. Pietro Bersani CPA, J.D.
Sector: Healthcare
Employees: 35
Address: 7707 Fannin, Houston, TX 77054
Phone: 832 968 4888
Leadership
- Pietro Bersani, CPA, Director
- Leonardo Mirandola, PhD, Chief Scientific Officer/Interim COO
- Scott Dahlbeck, MD, PharmD, Chief of Staff
- Brian Hungerford, Chief Financial Officer
- Michael Nagel, Chairperson
- Michael Catlin, Independent Director
- Pam Misajon, Independent Director
Last updated: 2024-12-31
Novavax, Inc.
NVX-Co V2373
Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Their vaccine candidates include NVX-Co V2373, Nano Flu, and Res Vax. The company operates collaboratively with Takeda Pharmaceutical Company Limited on COVID-19 vaccine development.
Contact | Careers | Careers | Careers | Careers | About | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | About | About
Symbol: NVAX
Recent Price: $7.93
Industry: Biotechnology
CEO: Mr. John Charles Jacobs M.B.A.
Sector: Healthcare
Employees: 1543
Address: 21 Firstfield Road, Gaithersburg, MD 20878
Phone: 240 268 2000
Last updated: 2024-12-31
Pyxis Oncology, Inc.
PYX-106, PYX-102, PYX-201, PYX-202, PYX-203
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.
Symbol: PYXS
Recent Price: $1.56
Industry: Biotechnology
CEO: Dr. Lara S. Sullivan M.D., MBA
Sector: Healthcare
Employees: 55
Address: 35 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 221 9059
Last updated: 2024-12-31
Acrivon Therapeutics, Inc. Common Stock
Acrivon Predictive Precision Proteomics
Acrivon Therapeutics is a clinical stage biopharmaceutical company developing oncology medicines using a proteomics-based platform to identify patient responders. Their lead candidate, ACR-368, is in Phase 2 trials for various cancers.
Symbol: ACRV
Recent Price: $5.41
Industry: Biotechnology
CEO: Dr. Peter Blume-Jensen M.D., Ph.D.
Sector: Healthcare
Employees: 58
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 617-207-8979
Last updated: 2024-12-31
Apollomics, Inc.
APL-101 (Vebreltinib), APL-102, APL-122
Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.
Symbol: APLM
Recent Price: $10.13
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Sector: Healthcare
Employees: 45
Address: 989 East Hillsdale Blvd, Foster City, CA 94404
Phone: 650 209 4055
Last updated: 2024-12-31
Corvus Pharmaceuticals, Inc.
Mupadolimab (CPI-006)
Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing immuno-oncology therapies, including Mupadolimab for non-small cell lung cancer, CPI-818 for T-cell lymphomas, and Ciforadenant for renal cell cancer.
Symbol: CRVS
Recent Price: $5.25
Industry: Biotechnology
CEO: Dr. Richard A. Miller M.D.
Sector: Healthcare
Employees: 28
Address: 863 Mitten Road, Burlingame, CA 94010
Phone: 650 900 4520
Last updated: 2024-12-31
Inovio Pharmaceuticals, Inc.
DNA Medicines
Inovio Pharmaceuticals is a biotechnology company focused on discovering, developing, and commercializing DNA medicines to treat and protect against diseases like HPV, cancer, and infectious diseases. Their platform includes Syn Con designed DNA sequences and CELLECTRA smart devices technology for delivery.
Vision/Values | Leadership | About | Leadership | Vision/Values | About | Contact | Careers | Careers | About | About | About | About | About
Symbol: INO
Recent Price: $1.78
Industry: Biotechnology
CEO: Dr. Jacqueline E. Shea Ph.D.
Sector: Healthcare
Employees: 127
Address: 660 West Germantown Pike, Plymouth Meeting, PA 19462
Phone: 267 440 4200
Leadership
- Jacqueline Shea, Ph.D., President & Chief Executive Officer
- Peter Kies, Chief Financial Officer
- Michael Sumner, MB BS, MBA, Chief Medical Officer
- Laurent Humeau, Ph.D., Chief Scientific Officer; Chairman, Scientific Advisory Board
- Steve Egge, MBA, Chief Commercial Officer
- Rob Crotty, J.D., General Counsel and Chief Compliance Officer
- EJ Brandreth, MBA, Senior Vice President, Quality Assurance
- Shawn Bridy, MA, MBA, Senior Vice President, Business Development
- Cheryl Elder, PharmD, Senior Vice President, Regulatory Affairs
- Robert J. Juba Jr., Senior Vice President, Biological Manufacturing and Clinical Supply Management
- Jeffrey Skolnik, M.D., Senior Vice President, Clinical Development
- Dave Liebowitz, M.D. & Ph.D., Senior Vice President, Early-Stage Clinical Development
- Simon X. Benito, Chairman of the Board, Inovio Pharmaceuticals
- Roger D. Dansey, M.D., Chief Medical Officer at Seagen
- Ann C. Miller, M.D., Former Head of Sanofi Oncology Global Marketing
- Jay Shepard, Former President & CEO of Aravive
- David B. Weiner, Ph.D., Executive Vice President, Director, Vaccine Center, The Wistar Institute
- Wendy L. Yarno, MBA, Former Executive Vice President and Chief Marketing Officer at Merck & Co., Inc.
- Lota S. Zoth, CPA, Former Chief Financial Officer, MedImmune
- Rafi Ahmed, Ph.D., Director, Emory Vaccine Center, Emory University School of Medicine
- Stanley A. Plotkin, M.D., Emeritus Professor, Wistar Institute and University of Pennsylvania; Principal, Vaxconsult
Last updated: 2024-12-31
Kala Pharmaceuticals, Inc.
KPI-012, EYSUVIS, INVELTYS
Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for eye diseases using proprietary mucus penetrating particles technology.
Contact | Careers | Jobs | Careers | Careers | Careers | Careers | Leadership | Careers | Contact | Careers | Careers | Careers | About
Symbol: KALA
Recent Price: $6.87
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Mark T. Iwicki
Sector: Healthcare
Employees: 43
Address: 1167 Massachusetts Avenue, Arlington, MA 02476
Phone: 781 996 5252
Last updated: 2024-12-31
Karyopharm Therapeutics Inc.
XPOVIO
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing drugs targeting nuclear export for the treatment of cancer and other diseases, with a flagship product named XPOVIO.
Symbol: KPTI
Recent Price: $0.70
Industry: Biotechnology
CEO: Mr. Richard A. Paulson M.B.A.
Sector: Healthcare
Employees: 325
Address: 85 Wells Avenue, Newton, MA 02459
Phone: 617 658 0600
Leadership
- Richard Paulson, President and Chief Executive Officer
- James Accumanno, Chief Compliance Officer
- Brian Austad, Senior Vice President, Pharmaceutical Sciences
- Sohanya Cheng, Chief Commercial Officer and Head of Business Development
- Lisa DiPaolo, Chief Human Resources Officer
- Mike Mano, Senior Vice President and General Counsel
- Michael Mason, Chief Financial Officer
- Stuart Poulton, Chief Development Officer
- Reshma Rangwala, Chief Medical Officer & Head of Research
- Amama Sadiq, Senior Vice President, Global Medical and Scientific Affairs
- Elhan Webb, Senior Vice President, Investor Relations
- Garen Bohlin, Director
- Barry E. Greene, Lead Director
- Mansoor Raza Mirza, MD, Director
- Richard Paulson, MBA, President and Chief Executive Officer
- Christy J. Oliger, Director
- Deepa R. Pakianathan, PhD, Director
- Chen Schor, Director
- Zhen Su, MD, MBA, Director
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
Xenetic Biosciences, Inc.
XCART
Xenetic Biosciences, Inc. is a biopharmaceutical company that focuses on advancing XCART, a personalized CAR T platform technology for oncology therapeutics and biologic drug development.
About | Leadership | Directors | About | About | About | Contact | Careers | About | About | About
Symbol: XBIO
Recent Price: $4.05
Industry: Biotechnology
CEO: Mr. James F. Parslow
Sector: Healthcare
Employees: 4
Address: 40 Speen Street, Framingham, MA 01701
Phone: 781 778 7720
Leadership
- James F. Parslow, Interim Chief Executive Officer and Chief Financial Officer
- Scott N. Cullison, Business Development
- Reid P. Bissonnette, Ph.D., Translational Research and Development
- Cory C. Kauffman, Ph.D., Chief Technology Officer
- Adam Logal, Chairman
- Grigory G. Borisenko, Ph.D., Non-Executive Director
- James Eric Callaway, Ph.D., Non-Executive Director
- Firdaus Jal Dastoor, FCS, Non-Executive Director
- Dmitry Genkin, MD, Non-Executive Director
- Roger Kornberg, Ph.D., Non-Executive Director
- Moshe Mizrahy, Non-Executive Director
- Dr. Alexey Vinogradov, Non-Executive Director
Last updated: 2024-12-31
X4 Pharmaceuticals, Inc.
mavorixafor
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.
Symbol: XFOR
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Paula Ragan Ph.D.
Sector: Healthcare
Employees: 127
Address: 61 North Beacon Street, Boston, MA 02134
Phone: 857 529 8300
Last updated: 2024-12-31
Xilio Therapeutics, Inc.
XTX101
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients with a focus on tumor-selective therapies.
Symbol: XLO
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Rene Russo BCPS, Pharm.D.
Sector: Healthcare
Employees: 73
Address: 828 Winter Street, Waltham, MA 02451
Phone: 617 430 4680
Last updated: 2024-12-31
XOMA Corporation
Pre-commercial therapeutic candidates
XOMA Corporation operates as a biotechnology royalty aggregator focusing on enhancing human health by acquiring potential future economics from pre-commercial therapeutic candidates licensed to pharmaceutical or biotech companies. With a portfolio of approximately 70 assets, it focuses on early to mid-stage clinical assets with commercial sales potential.
Symbol: XOMA
Recent Price: $26.09
Industry: Biotechnology
CEO: Mr. Owen P. Hughes Jr.
Sector: Healthcare
Employees: 13
Address: 2200 Powell Street, EmeryVille, CA 94608
Phone: 510 204 7200
Last updated: 2024-12-31
Aptevo Therapeutics Inc.
APVO436
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company specializing in the development of immunotherapeutic candidates to treat various forms of cancer, with a primary focus on APVO436, a bispecific T-cell engaging antibody for leukemia and myelodysplastic syndrome.
About | Leadership | Directors | About | Contact | About | Contact | Contact | Contact | About | Leadership | Directors | About | About | About | About | About | About | About | About | About | About | About
Symbol: APVO
Recent Price: $4.78
Industry: Biotechnology
CEO: Mr. Marvin L. White
Sector: Healthcare
Employees: 40
Address: 2401 4th Avenue, Seattle, WA 98121
Phone: 206 838 0500
Leadership
- Marvin L. White, President and Chief Executive Officer
- Jeff Lamothe, EVP and Chief Operating Officer
- Daphne Taylor, SVP and Chief Financial Officer
- Dirk Huebner, M.D., Chief Medical Officer
- SoYoung Kwon, SVP, General Counsel, Business Development and Corporate Affairs
Last updated: 2024-12-31
Exelixis, Inc.
CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.
Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers
Symbol: EXEL
Recent Price: $33.70
Industry: Biotechnology
CEO: Dr. Michael M. Morrissey Ph.D.
Sector: Healthcare
Employees: 1310
Address: 1851 Harbor Bay Parkway, Alameda, CA 94502
Phone: 650 837 7000
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31
PaxMedica, Inc. Common Stock
PAX-101
Pax Medica, Inc., is a clinical stage biopharmaceutical company focused on developing anti-purinergic drug therapies for treating intractable neurologic disorders. Their lead product, PAX-101, is an intravenous formulation of suramin for indications such as autism spectrum disorder and chronic fatigue syndrome.
Symbol: PXMD
Recent Price: $0.06
Industry: Biotechnology
CEO: Mr. Howard J. Weisman
Sector: Healthcare
Employees: 6
Address: 303 South Broadway, Tarrytown, NY 10591
Phone: 914-987-2876
Last updated: 2024-12-31